Page last updated: 2024-08-25

bexarotene and Triple Negative Breast Neoplasms

bexarotene has been researched along with Triple Negative Breast Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, L; Kumar, D; Lee, J; Long, C; Nguyen, J	1

Other Studies

1 other study(ies) available for bexarotene and Triple Negative Breast Neoplasms

Article	Year
Discovering alkylamide derivatives of bexarotene as new therapeutic agents against triple-negative breast cancer. Bioorganic & medicinal chemistry letters, 2018, 02-01, Volume: 28, Issue:3 Topics: Amides; Antineoplastic Agents; Apoptosis; Bexarotene; Cell Line; Cell Proliferation; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Female; Humans; Molecular Structure; Structure-Activity Relationship; Triple Negative Breast Neoplasms	2018

Article

Year

Discovering alkylamide derivatives of bexarotene as new therapeutic agents against triple-negative breast cancer.

Bioorganic & medicinal chemistry letters, 2018, 02-01, Volume: 28, Issue:3

Topics: Amides; Antineoplastic Agents; Apoptosis; Bexarotene; Cell Line; Cell Proliferation; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Female; Humans; Molecular Structure; Structure-Activity Relationship; Triple Negative Breast Neoplasms

2018